First, most of the production enterprises are private enterprises, with flexible operations and small investment scale, basically between several million and one or two thousand yuan;
Second, the geographical distribution of production enterprises is relatively concentrated, mainly in the areas centered on Taizhou, Zhejiang and Jintan, Jiangsu;
Third, with the increasing emphasis on environmental protection issues by the state, the pressure on production companies to build environmentally friendly treatment facilities has increased;
Fourth, the product update speed is fast. After a product is generally available for 3 to 5 years, its profit margin will drop drastically, forcing companies to continuously develop new products or continuously improve production processes in order to maintain high production profits;
Fifth, because the production profit of pharmaceutical intermediates is higher than that of chemical products, the production process of the two is basically the same, so more and more small chemical companies have joined the ranks of producing pharmaceutical intermediates, resulting in increasingly fierce competition in the industry. ;
Sixth, compared with raw materials, the profit margin of production intermediates is low, and the production process of APIs and pharmaceutical intermediates is similar. Therefore, some enterprises have not only produced intermediates, but also used their own advantages to start producing APIs.